Warning: session_start(): open(/opt/alt/php74/var/lib/php/session/sess_536cd3616312b21655cb7b07dc594223, O_RDWR) failed: Disk quota exceeded (122) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278

Warning: session_start(): Failed to read session data: files (path: /opt/alt/php74/var/lib/php/session) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278
Israel: A World Leader in Scientific Research Focused on Medical Marijuana - Mushroomstocks | Mushroomstocks
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Israel: A World Leader in Scientific Research Focused on Medical Marijuana

Feb 2, 2015 • 1:09 AM EST
3 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Medical marijuana has not only been a hot topic in the United States but in other countries as well. Israel began to research the medical uses of marijuana 50 years ago and is now a world leader in the field. Investors have begun to express interest in their “botanical high-tech” medical cannabis industry.

In May 2014, MedReleaf, a Canadian medical marijuana producer, entered into a partnership with an Israeli producer, Tikun Olam, for a strain of cannabis that benefits epileptic children. The non-euphoric strain, called Rafael, helps reduce the number of seizures that such children have; in Israel it is available in oral doses.

“Tikun Olam shares their 10 years of data, so we can say, ‘Our Israeli partner has treated 817 patients with Crohn’s or Colitus or Alzheimer’s, and they know that this variety with this dosage, is the optimum,” said Neil J. Closer, MedReleaf’s chief executive.

Innovation around the world

PhytoTech Medical, an Australian medical cannabis company that recently went public and raised $6 million through its public offering, announced a deal Monday with Yissum, the technology transfer arm of Jerusalem’s Hebrew University, to develop precisely dosed pills for the mainstream pharmaceutical market.

On Thursday, Israeli marijuana producers will hold an investors conference called Canna Tech Israel. The conference will feature Dr. Alan Shackelford, Charlotte Figi’s doctor. Charlotte has suffered from Dravet’s Syndrome and the strain Charlotte’s Web is named after her.

“Israel is a bastion of cannabis research,” said Shackelford, who is now the chief science officer for One World Cannabis, publicly traded as OWC Pharmaceuticals.

After seeing U.S. drug laws block clinical studies into promising applications that treat illnesses that conventional medicine cannot treat, Shackelford, a Harvard-trained physician, began to conduct research in Israel. This year, Shackelford will lead studies on chronic pain, skin disorders, seizure disorders, several types of cancers, migraine headaches, and post-traumatic stress disorder (PTSD).

“I went to Israel because I was frustrated,” he said. “Israel is the one place in the world that combines the scientific expertise, world-class universities and scientists. It’s so exciting.”

Syqe Medical will also be featured in the conference on Thursday. The company received a $1 million grant from the state and have developed a metered-dose cannabis inhaler.

Israel leading the curve in marijuana research

Israel has become a world leader in scientific research focused on the medical uses of marijuana. Experts have said that Israeli producers could become major exporters of medical cannabis. The Israeli government, however, does not allow producers to export their product.

Health ministers around the world have visited the country hoping to land a deal with the government, but have not had success in getting a deal to import Israeli cannabis.

Michael Dor, the senior medical adviser in the Israeli Health Ministry’s cannabis unit, said that in ongoing government talks, agricultural officials support the export of Israeli medical cannabis, but top officials in the police force, the army and the executive branch oppose it. Dor said that exports face stringent international legal requirements, and those officials “don’t want Israel to be seen all over the world as a country that exports weapons and cannabis.”

If Israel does not export medical cannabis, there is a risk that “the knowledge will leak outside Israel, and the knowledge is worth a lot of money,” Dor said. “We would like to stay in the forefront.”

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.

Fatal error: Uncaught ErrorException: md5_file(/home/useaicwl/public_html/wp-content/litespeed/css/afcc0c1d71f26450b5ad85f64f7f4802.css.tmp): failed to open stream: No such file or directory in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php:126 Stack trace: #0 [internal function]: litespeed_exception_handler(2, 'md5_file(/home/...', '/home/useaicwl/...', 126, Array) #1 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php(126): md5_file('/home/useaicwl/...') #2 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(797): LiteSpeed\Optimizer->serve('https://mushroo...', 'css', true, Array) #3 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(319): LiteSpeed\Optimize->_build_hash_url(Array) #4 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(252): LiteSpeed\Optimize->_optimize() #5 /home/useaicwl/public_html/wp-includes/class-wp-hook.php(310): LiteSpeed\Optimize->f in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php on line 126